[
    [
        {
            "time": "",
            "original_text": "【医药丨周小刚】凯莱英(002821)：创新药 CDMO 需求持续提升， 技术驱动长期可持续发展",
            "features": {
                "keywords": [
                    "凯莱英",
                    "创新药",
                    "CDMO",
                    "需求持续提升",
                    "技术驱动",
                    "长期可持续发展"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【医药丨周小刚】凯莱英(002821)：创新药 CDMO 需求持续提升， 技术驱动长期可持续发展",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]